Number of S, I and R to six antibiotics

Slides:



Advertisements
Similar presentations
Surveillance of antimicrobial resistance Liselotte Högberg Swedish Institute for Infectious Disease Control
Advertisements

Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.
MRSA Definition Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA is by definition.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
SWEDRES 2004 Figures and Tables. SWEDRES 2004 Table Total use of antobacterial drugs in Sweden DDD/1000/day Data source: The National.
MALDI TOF analysis of Streptococcus pneumoniae from Cerebrospinal Fluid for the diagnosis of Acute Bacterial Meningitis Dr. R. Ravikumar, M.D., Professor.
EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.
K. Loens, E. De Herdt, S. Verkroost, C. Lammens, M. Ieven and H. Goossens Surveillance of invasive Group A Streptococci in Belgium (01/01/ /12/2014)
Antimicrobial susceptibility patterns of Polish invasive isolates of Neisseria meningitidis in the years Marcin Kadłubowski 1, Anna Skoczyńska.
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Fever in infants: Evaluation by
This poster will be made available for download after the meeting at :
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.
C-672b First report of Group B Streptococcus Isolates with Cross-resistance to Lincosamides, Streptogramin A, and Pleuromutilins in the United States P.
at George Washington University Medical Center, Washington, DC
Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990  Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl 
Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco)  Karima.
Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden   E. Persson, S. Berg, B. Trollfors, P.
R. Leclercq  Clinical Microbiology and Infection 
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
State-wide surveillance of antibiotic resistance patterns and spa types of methicillin- resistant Staphylococcus aureus from blood cultures in North Rhine-Westphalia,
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the.
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
E. Lindberg, I. Adlerberth, A.E. Wold 
Swedres 2007 Figures and tables Swedres 2007.
State-wide surveillance of antibiotic resistance patterns and spa types of methicillin- resistant Staphylococcus aureus from blood cultures in North Rhine-Westphalia,
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children.
Clinical Microbiology and Infection
Pneumococcal conjugate vaccines: overview of a decade from Kuwait
D.E. Low  Clinical Microbiology and Infection 
Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis  A. Egli,
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
…monitoring trends in antimicrobial resistance in Canada
Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.
Gonorrhoea antimicrobial resistance in Ireland, 2010 – 2017 On behalf of the National Forum on Antimicrobial Resistance in Neisseria gonorrhoeae Health.
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
ANTIMICROBIAL USE AND RESISTANCE SURVEILLANCE PILOT PROJECT – LESSONS FROM THE DURBAN SITE Gray AL, Essack SY, Deedat F, Pillay T, van Maasdyk J, Holloway.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media;
Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis  S.R. Norrby, J. Quinn, M. Rangaraju,
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
C. Oprica, C.E. Nord  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical Microbiology and Infection
Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990  Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl 
Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories  E. Matuschek,
…monitoring trends in antimicrobial resistance in Canada
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
Modification of prescribers’ behavior: the Icelandic approach
European recommendations for antimicrobial resistance surveillance
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis  A. Egli,
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Fernando Baquero, John F
Presentation transcript:

Number of S, I and R to six antibiotics Poster at the 15th ECCMID, April 2-5 2005, Copenhagen Antibiotic Resistance among invasive pneumococcal Isolates from Southwest Sweden 1998-2001 Erik Backhaus1, Birger Trollfors2, Stefan Berg2, Berndt EB Claesson1, Rune Andersson. 1. 1Department of Infectious Diseases and Clinical Microbiology, Kärnsjukhuset, Skövde, 2Department of Paediatrics, The Queen Silvia Children's Hospital, Göteborg,SwedenCorrespondence: erik.backhaus@vgregion.se The abstract has been slightly revised with addition of new data. Objectives Streptococcus pneumoniae is a major human pathogen. In Southwest Sweden, with a population of 1.8 million, 200 patients are diagnosed each year with invasive pneumococcal disease. The rapid emergence of isolates with decreased susceptibility to several antibiotics is an increasing problem in many parts of the world. The aim of the present study was to investigate the pattern of susceptibility among invasive isolates, in order to see if the current treatment policies are appropriate, and to see if there seems to be a trend of increasing antibiotic resistance. Methods All clinical isolates of S. pneumoniae from blood, cerebrospinal and joint fluid were collected at the laboratories in Göteborg, Skövde, Borås, Uddevalla and Halmstad during 1998-2001. The MIC-values for seven commonly used antibiotics (penicillin G, erythromycin, clindamycin, tetracycline, moxifloxacin, cotrimoxazole and cefotaxime) were determined with E-test (AB Biodisk) according to standard methods. E-test Distribution of MIC’s Serotype distribution Results 827 invasive strains were tested. Of these, 766 were fully susceptible and 61 (7.4%) were classified as Indeterminate (I) or Resistant (R) for any of the tested antibiotics, according to the Swedish Reference Group for Antibiotics system of species related breakpoints. No isolate had a MIC>1.0 mg/L against penicillin (R). 22 isolates (2.7%) were classified as I to penicillin (MIC >0.06, 1.0 mg/L). 13 of them had MIC’s  0.5 mg/L. Among the 22 isolates classified as I to penicillin 12 isolates were also I against cefotaxime (MIC >0.12, 1.0 mg/L) (1.5%).   The other tested antibiotics showed the following results: Erythromycin R (MIC >0.5 mg/L) 30 isolates (3.6%), clindamycin R (MIC>2 mg/L) 6 isolates (0.7%), tetracycline R (MIC>2mg/L) 16 isolates (1,9%), and moxifloxacin R (MIC>0,5 mg/L) 1 isolate (0.1%). There were no isolates classified as I for those antibiotics. There were 21 isolates (2,5%) classified as I against cotrimoxazole (MIC >16, 32 mg/L), but no R (MIC>32 mg/L). Conclusion The proportion of invasive isolates of pneumococci with decreased sensitivity to commonly used antibiotics is very low. Our results indicate that there might be a clonal spread of isolates of serotype 9V and 14 with reduced susceptibility to antibiotics. 61 isolates with elevated MIC All isolates (827 patients) Antibiotic agent MIC 50 MIC 90 median 90 percentile mg/L Penicillin G 0.016 0.023 Erythromycin 0.190 0.250 Clindamycin Tetracycline 0.125 Moxifloxacin Trim /Sulfa 1/19*** 0.5 1 12,5% 15,6% 7,8% 43,8% Other 9V 6B 19F 19A 14 1 17,8% 8,6% 8,5% 14,3% Other 9V 9N 8 7F 6B 6A 4 3 23F 19A 14 12F 1 Number of S, I and R to six antibiotics Sensitivity pattern and serotypes Antibiotic agent Total Sensitive Indeterminate Resistant number breakpoint** Penicillin G 827 805 < 0.06 mg/L 22(2.7%) >1.0 mg/L Erythromycin 797 0.5 mg/L n.r.* 30 (3.6%) >0.5 mg/L Clindamycin 821 2 mg/L 6 (0.7%) >2 mg/L Tetracycline 811 16 (1.9%) Moxifloxacin 826 1 (0.1%) Trim/Sulfa 1/19*** 815 16 mg/L 21(2.5%) >32 mg/L ** Species related breakpoints according to the Swedish Reference Group for Antibiotics system. *** Values on the MIC scale refer to the first component of the combination. *not relevant Distribution of MIC values for 827 invasive strains of Streptococcus pneumoniae Penicillin G Erythromycin Clindamycin Tetracycline Moxifloxacin Trimethoprim/sulphamethoxazole MIC (mg/L) 1 ,75 ,50 ,380 ,250 ,190 ,125 ,094 ,064 ,047 ,032 ,023 ,016 ,012 ,008 ,006 Number 400 300 200 100 S I R 1,5 2 MIC (mg/L) ,500 ,380 ,250 ,190 ,125 ,094 ,064 Number 400 300 200 100 256 128 64 48 32 24 16 12 S R MIC (mg/L) 256 ,500 ,380 ,250 ,190 ,125 ,094 ,064 Number 400 300 200 100 S R MIC (mg/L) ,750 ,500 ,380 ,250 ,190 ,125 ,094 ,064 Number 500 400 300 200 100 48 32 24 16 8 4 2 6 3 1,5 S R 1 12 64 MIC (mg/L) 8 ,380 ,250 ,190 ,125 ,094 ,064 ,047 Number 500 400 300 200 100 S R MIC (mg/L) 32 8 6 4 3 2 1,500 1,0 ,75 ,50 ,380 ,250 ,190 ,125 ,064 Number 400 300 200 100 S I R 48 64